Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jutian Shi"'
Autor:
Jinpeng Li, Mingxin Kong, Guangji Yu, Song Wang, Zhaozhang Shi, Huihui Han, Yanyan Lin, Jutian Shi, Jinlong Song
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
ObjectiveThis study was aimed to evaluate the efficacy and safety of transarterial chemoembolization combined with tyrosine kinase inhibitors and camrelizumab in the treatment of unresectable hepatocellular carcinoma and to explore a new therapeutic
Externí odkaz:
https://doaj.org/article/0cbc081f76d84442a0fbe2ca6a46d5ed
Publikováno v:
Journal of Clinical Oncology. 40:e16190-e16190
e16190 Background: The prognosis for advanced hepatocellular carcinoma (HCC) is still very poor. This study aimed to explore the efficacy and safety of transcatheter arterial chemoembolization (TACE) combined with camrelizumab plus targeted therapy f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9925e262cdd717d102b1617f534a7f29
https://doi.org/10.1200/jco.2022.40.16_suppl.e16190
https://doi.org/10.1200/jco.2022.40.16_suppl.e16190
Publikováno v:
Archives of Clinical and Medical Case Reports.
DEBs?Drug-eluting microspheres) is a new embolic agent in recent years, which can achieve the dual effects of embolization and local drug release, and achieve more satisfactory tumor response rate and survival time than C-TACE?conventional transcathe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::956f1886d6019254c5b769e2208eee55
https://doi.org/10.26502/acmcr.96550204
https://doi.org/10.26502/acmcr.96550204
Publikováno v:
Medicine; 11/5/2021, Vol. 100 Issue 44, pe27636-e27636, 1p